Intravenous immunoglobulin (IVIg) is an effective treatment for a wide range of autoimmune neurological disorders. IVIg is well tolerated in general but may rarely result in anaphylaxis and acute renal failure, as well as thromboembolic complications such as pulmonary embolism and stroke. These recent reports in Neurology highlight the potential vascular consequences of IVIg.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content